An exploration on the influence of positive simple thyroid peroxidase antibody on female infertility
- Authors:
- Published online on: August 2, 2018 https://doi.org/10.3892/etm.2018.6561
- Pages: 3077-3081
Abstract
Introduction
Infertility is currently a common disease in women at childbearing age. With the acceleration of social processes, the morbidity of infertility is increased gradually throughout the world at present. In developed countries, 10–15% of couples suffer from infertility (1). Common causes of infertility include factors of male infertility, female infertility, infertility in couples and unexplained infertility (2–4), among which factors of female infertility take up the most. Meanwhile, female infertility is caused by the following definite reasons: Immune infertility, tubal obstruction and ovulatory dysfunction (5,6). Zhong et al (7), showed that in vitro fertilization rates and embryo implantation rate was significantly reduced in anti-thyroid antibody-positive patients. At present, the number of infertile women in China is increased year by year, which requires us to find more effective influence indicators to judge and find out the causes of infertility in a better way.
Materials and methods
General data
Objects of study: A total of 529 infertile females that received treatments in The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University from January 2014 to January 2017 and complied with inclusion criteria were selected for retrospective study. They were divided into positive group (121 patients) and negative group (408 patients). The patients were 22–43 years with an average age of 30.5±5.9. General data of the patients, including age, height, body weight, initial menstruation, duration of infertility, menstrual cycle, permanent residence (city/village) and education background (university degree or above/under university degree) are given in Table I. The present study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University (Wuxi, China). All the participants or their family members signed written informed consent.
Inclusion criteria: i) Married women at childbearing age (20–49 years old); ii) patients complying with World Health Organization (WHO) diagnostic criteria for female infertility: females with sexual life; females without pregnancy or abortion; females without pregnancy while no contraceptive measure was taken within 1 year; iii) patients with normal thyroid function and thyroid autoantibodies [thyroglobulin antibody (TG-Ab), thyroid peroxidase antibody (TPO-Ab) and thyroid microsome antibody (TM-Ab)]; iv) patients with positive TPO-Ab (a thyroid autoantibody) and normal TG-Ab and TM-Ab. Patients meeting item i, ii and iii were grouped into negative control group (negative group for short), and those meeting item i, ii and iv into positive simple TPO-Ab group (positive group for short).
Exclusion criteria: i) patients with a history of diabetes, coronary heart disease, hyperlipidemia, hypertension, diseases caused by hypothalamic or pituitary dysfunction, malignant tumors, substantial lesions of organs such as liver and kidney, etc.; and ii) patients with a history of thyroid diseases (whether or not cured), patients with recent oral administration of drugs that can affect thyroid function and blood lipid levels, patients with a history of thyroid antibody positive.
Laboratory examinations
Venous blood was collected from all the included infertile females on an empty stomach in the morning from the 2nd day to the 4th day after menstruation to measure basal hormone levels. The levels of human follicle stimulating hormone (hFSH), estradiol (ESTRDL), progesterone (Prog), prolactin (PRL), testosterone (TESTO) and human luteinizing hormone (hLH) in the serum were measured by chemiluminescence method (Beijing Craymei Biotech Co., Ltd., Beijing, China). All the items of blood drawing were conducted by professional nurses, and relevant tests and results were completed and judged, respectively by two specific laboratory physicians.
Confirmation on causes of infertility
The causes of female infertility were determined and studied by inquiry of medical history, general gynecological examination, detection of basal hormone levels, B-scan ultrasonography, tubal and uterine lipiodol angiography (8), laparoscopy, hysteroscopy, surgical pathologic examination and other ways. In addition, polycystic ovarian syndrome (PCOS) was diagnosed as per industry standard of the Ministry of Health (2011).
Comparisons of relative indicators among groups
The correlation of positive simple TPO-Ab with the diseases of infertility such as endometriosis (EMT), PCOS, tubal obstruction and premature ovarian failure (POF) was compared. All the patients were divided into three age groups (22–28, 28–35 and 35–42 years old) to analyze and compare the correlation of infertility with positive simple TOP-Ab.
Statistical analysis
All the data were processed using SPSS v.20.0 software (IBM Corp., Armonk, NY, USA). The measurement data were expressed as the mean ± standard deviation. Data between the two groups was compared by t-test. Enumeration data was expressed as percentages, and the Chi-square test was performed for data analysis. P<0.05 was considered to indicate a statistically significant difference.
Results
Comparisons of BMI and basal hormone levels in the serum between the two groups
A total of 529 infertile females were included in this study. The differences in body mass index (BMI) and basal hormone levels (hFSH, ESTRD, Prog, PRL, TESTO and hLH) had no statistical significance (P>0.05; Table II).
Comparison of incidence rates of diseases of infertility between the two groups
The comparison of menstruation between the two groups of patients showed no statistical significance (P>0.05). The incidence rates of tubal obstruction and POF in the positive group were lower than those in the negative group, but the differences between the two groups were not significant (P>0.05). However, the differences in the incidence rates of EMT and PCOS between the two groups of females were significant (P<0.05), and the incidence rate of PCOS was relatively significant in females with positive simple TPO-Ab (P<0.001; Table III).
Comparisons of the number of patients with EMT, PCOS among different age groups
In the present study, the numbers of patients with EMT and PCOS were compared among different age groups. The results showed that patients aged 28–35 years old took up the most in terms of EMT and PCOS (Fig. 1), among which the comparison of the percentage of positive simple TOP-Ab among the three age groups with EMT had no statistical difference (χ2=1.005; P=0.605; Fig. 2), while patients with PCOS aged 28–35 years showed relatively high percentage of positive simple TPO-Ab (χ2=6.689; P=0.035; Fig. 3).
Discussion
TPO is a thyroid-specific antigen, which destroys thyroid tissue mainly through infiltrating lymphocytes, thus resulting in autoimmune thyroid disease (AITD) (9). Currently, the correlation between AITD and recurrent miscarriage and pregnancy loss is confirmed in many studies (10–12), while the interference of thyroid autoantibodies in the normal fertility of women of childbearing age is still an outstanding problem (13–15). At present, there are relatively few studies on the influence of positive TPO-Ab on infertility. Therefore, a total of 529 infertile females were selected for experimental study so as to confirm the potential influence of positive TPO-Ab on infertility.
The results of the present study showed that basal hormone levels and BMI had no significant differences in females with positive simple TPO-Ab and normal thyroid function (P>0.05), while the percentages were relatively high in infertile females with positive simple TPO-Ab, and the expressions in EMT and PCOS were significant (P<0.05). A study of Chen et al (15) showed that the incidence rate of positive TPO-Ab is high in infertile females, which is significantly related to idiopathic poor ovarian reserve function (P=0.020), leading to more unexplained infertility. A study of Medenica et al (16) showed that positive TPO-Ab is significantly correlated with EMT (P=0.001). A study conducted by Drobniak et al (17) showed that increased TPO-Ab is observed in 12–25% of females with autoimmune thyroid diseases, while the positive rate of TPO-Ab in females with PCOS and EMT is increased significantly, and TPO-Ab with a high titer is observed more frequently. A study of Sinha et al (18) showed that the positive rate of anti-TPO-Ab in patients with PCOS is increased (P<0.05), which is more significant in infertile patients with positive TPO-Ab than that in the control group (22.5% vs. 1.25%, P<0.01). Another study of Weghofer et al (19) also showed that the incidence rate of anti-TPO-Ab in patients with PCOS is significantly higher than that in the control group (normal females) (P<0.01). The aforementioned test results are basically identical with those of this study, which suggests that positive simple TPO-Ab may be correlated with female infertility caused by EMT and PCOS, while the mechanism of infertility of patients with EMT and PCOS caused by increased TPO-Ab still needs to be explored further.
There was no statistically significant difference in the incidence rate of EMT among the three age groups at different ages (P=0.605), while the positive rate of TPO-Ab in infertile females with PCOS aged 28–35 years old was increased significantly (P=0.035), which suggests that positive simple TPO-Ab may have a greater impact on infertile females aged 28–35 years (20,21).
This experimental study still has some shortcomings. The conditions of infertile females with positive TPO-Ab after treatment can be further analyzed to provide more support for this experimental study. As the experimental samples have regional limitations, a multi-center study on a large sample size can prove the significance of the experiment in a more powerful way.
In conclusion, positive simple TPO-Ab may be correlated with EMT and PCOS. Patients with EMT and PCOS (especially females with PCOS aged 28–35 years old) should undergo screening of thyroid autoantibodies actively to provide better interventions.
Acknowledgements
Not applicable.
Funding
No funding was received.
Availability of data and materials
The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.
Authors' contributions
XW and XD conceived and designed the study. XX collected the patient data. FX and RF were responsible for the analysis and interpretation of the data. XW drafted this manuscript. XD revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The present study was approved by the Ethics Committee of The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University (Wuxi, China). Signed written informed consent was obtained from the patients and/or their guardians.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
Carp HJ, Selmi C and Shoenfeld Y: The autoimmune bases of infertility and pregnancy loss. J Autoimmun. 38:J266–J274. 2012. View Article : Google Scholar : PubMed/NCBI | |
Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L and Hoffmann P: Female infertility and serum auto-antibodies: A systematic review. Clin Rev Allergy Immunol. 53:78–86. 2017. View Article : Google Scholar : PubMed/NCBI | |
Mobeen H, Afzal N and Kashif M: Polycystic ovary syndrome may be an autoimmune disorder. Scientifica (Cairo). 2016:40717352016.doi: 10.1155/2016/4071735. PubMed/NCBI | |
Feldthusen AD, Pedersen PL, Larsen J, Kristensen Toft T, Ellervik C and Kvetny J: Impaired fertility associated with subclinical hypothyroidism and thyroid autoimmunity: The Danish General Suburban Population Study. J Pregnancy. 2015:1327182015. View Article : Google Scholar : PubMed/NCBI | |
Busnelli A, Paffoni A, Fedele L and Somigliana E: The impact of thyroid autoimmunity on IVF/ICSI outcome: A systematic review and meta-analysis. Hum Reprod Update. 22:793–794. 2016. View Article : Google Scholar : PubMed/NCBI | |
Al-Saab R and Haddad S: Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: A case-control study from syria. Int J Endocrinol Metab. 12:e179542014. View Article : Google Scholar : PubMed/NCBI | |
Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q and Li J, Shen XT and Li J: Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci. 9:121–125. 2012. View Article : Google Scholar : PubMed/NCBI | |
Schankath AC, Fasching N, Urech-Ruh C, Hohl MK and Kubik-Huch RA: Hysterosalpingography in the workup of female infertility: Indications, technique and diagnostic findings. Insights Imaging. 3:475–483. 2012. View Article : Google Scholar : PubMed/NCBI | |
Unuane D, Velkeniers B, Anckaert E, Schiettecatte J, Tournaye H, Haentjens P and Poppe K: Thyroglobulin autoantibodies: Is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment? Thyroid. 23:1022–1028. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yoshioka W, Amino N, Ide A, Kang S, Kudo T, Nishihara E, Ito M, Nakamura H and Miyauchi A: Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility. Endocr J. 62:87–92. 2015. View Article : Google Scholar : PubMed/NCBI | |
Speer G: The impact of thyroid function in women of reproductive age: Infertility, pregnancy and the postpartum period. Orv Hetil. 154:2017–2023. 2013.(In Hungarian). View Article : Google Scholar : PubMed/NCBI | |
Boufas D, Vryonidou A, Mastorakos G and Ilias I: Thyroid function and autoimmunity versus number of pregnancies. J Reprod Infertil. 17:240–242. 2016.PubMed/NCBI | |
Plowden TC, Schisterman EF, Sjaarda LA, Zarek SM, Perkins NJ, Silver R, Galai N, DeCherney AH and Mumford SL: Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, or live birth. J Clin Endocrinol Metab. 101:2358–2365. 2016. View Article : Google Scholar : PubMed/NCBI | |
Duran B, Ozlü T, Koç O, Eşitken C and Topçuoğlu A: Relationship of thyroid hormone levels and thyroid autoantibodies with early pregnancy loss and infertility. J Obstet Gynaecol. 33:862–864. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chen CW, Huang YL, Huang RL, Tzeng CR and Chen CH: Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibodies. Thyroid. 27:1194–1200. 2017.PubMed/NCBI | |
Medenica S, Nedeljkovic O, Radojevic N, Stojkovic M, Trbojevic B and Pajovic B: Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci. 19:977–987. 2015.PubMed/NCBI | |
Drobniak A, Kanecki K, Grymowicz M and Radowicki S: Serum leptin concentration in women of reproductive age with euthyroid autoimmune thyroiditis. Gynecol Endocrinol. 32:128–131. 2016. View Article : Google Scholar : PubMed/NCBI | |
Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN and Pal SK: Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 17:304–309. 2013. View Article : Google Scholar : PubMed/NCBI | |
Weghofer A, Himaya E, Kushnir VA, Barad DH and Gleicher N: The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: A case-control study. Reprod Biol Endocrinol. 13:432015. View Article : Google Scholar : PubMed/NCBI | |
Andreeva P: Thyroid gland and fertility. Akush Ginekol (Sofiia). 53:18–23. 2014.(In Bulgarian). PubMed/NCBI | |
Fumarola A, Grani G, Romanzi D, Del Sordo M, Bianchini M, Aragona A, Tranquilli D and Aragona C: Thyroid function in infertile patients undergoing assisted reproduction. Am J Reprod Immunol. 70:336–341. 2013. View Article : Google Scholar : PubMed/NCBI |